0001169245-12-000001.txt : 20120618
0001169245-12-000001.hdr.sgml : 20120618
20120618100621
ACCESSION NUMBER: 0001169245-12-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20120618
DATE AS OF CHANGE: 20120618
EFFECTIVENESS DATE: 20120618
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001169245
IRS NUMBER: 030375697
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-40668
FILM NUMBER: 12911508
BUSINESS ADDRESS:
STREET 1: 4020 AERIAL CENTER PARKWAY
STREET 2: SUITE 101
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-535-8861
MAIL ADDRESS:
STREET 1: 4020 AERIAL CENTER PARKWAY
STREET 2: SUITE 101
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: Phase Biosciences Inc
DATE OF NAME CHANGE: 20061013
FORMER COMPANY:
FORMER CONFORMED NAME: DT BIOSCIENCES INC
DATE OF NAME CHANGE: 20020315
D/A
1
primary_doc.xml
X0705
D/A
LIVE
0001169245
PhaseBio Pharmaceuticals Inc
1 Great Valley Parkway
Suite 30
Malvern
PA
PENNSYLVANIA
19355
610-608-8563
DELAWARE
Phase Biosciences Inc
DT BIOSCIENCES INC
Corporation
true
Christopher
Prior
1 Great Valley Parkway
Suite 30
Malvern
PA
PENNSYLVANIA
19355
Executive Officer
Director
Joel
Sussman
1 Great Valley Parkway
Suite 30
Malvern
PA
PENNSYLVANIA
19355
Executive Officer
Ashutosh
Chilkoti
1001 Gloria Avenue
Durham
NC
NORTH CAROLINA
27701
Executive Officer
Director
Clay
Thorp
208 S. Mangum Street
Suite 350
Durham
NC
NORTH CAROLINA
27701
Director
Asish
K
Xavier
c/o Johnson & Johnson Dev Corporation
410 George Street
New Brunswick
NJ
NEW JERSEY
08901
Director
Guy
Fish
222 Berkeley Street
20th Floor
Boston
MA
MASSACHUSETTS
02116
Director
Robert
Ingram
280 S. Mangum Street
Suite 350
Durham
NC
NORTH CAROLINA
27701
Director
Craig
Rosen
370 Eagle Hill Road
Pasadena
MD
MARYLAND
21122
Director
Justin
Klein
5425 Wisconsin Avenue
Suite 800
Chevy Chase
MD
MARYLAND
20815
Director
James
Barrett
1119 St. Paul Street
Baltimore
MD
MARYLAND
21202
Director
Biotechnology
Decline to Disclose
- 06
true
0001169245-10-000001
2009-12-22
true
true
false
0
48524067
48524067
0
false
17
0
0
0
Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.
false
PhaseBio Pharmaceuticals Inc
/Christopher Prior, Ph.D./
Christopher Prior, Ph.D.
Chief Executive Officer
2012-06-15